You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Single dose oral etoricoxib for acute postoperative pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd004309.pub4 |
| Pubmed ID | |
| Authors |
Rachel Clarke, Sheena Derry, R Andrew Moore |
| Abstract |
This is an updated version of the original Cochrane review first published in Issue 2, 2009, and updated in Issue 4, 2012.Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor licensed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain in some jurisdictions. This class of drugs is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs). |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 25% |
| Spain | 3 | 19% |
| Belgium | 1 | 6% |
| Argentina | 1 | 6% |
| Colombia | 1 | 6% |
| United States | 1 | 6% |
| Australia | 1 | 6% |
| Unknown | 4 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 75% |
| Scientists | 3 | 19% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Norway | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 188 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 16% |
| Student > Bachelor | 17 | 9% |
| Researcher | 16 | 8% |
| Other | 15 | 8% |
| Student > Ph. D. Student | 14 | 7% |
| Other | 43 | 23% |
| Unknown | 56 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 46% |
| Nursing and Health Professions | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Chemistry | 5 | 3% |
| Psychology | 4 | 2% |
| Other | 13 | 7% |
| Unknown | 62 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2024.
All research outputs
#3,135,383
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#5,896
of 13,156 outputs
Outputs of similar age
#30,114
of 242,509 outputs
Outputs of similar age from Cochrane database of systematic reviews
#112
of 235 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,509 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.